Information Disclosure and Adverse Selection Explanations for IPO Underpricing

43 Pages Posted: 23 Jun 2002

See all articles by Catherine M. Schrand

Catherine M. Schrand

University of Pennsylvania - Accounting Department

Robert E. Verrecchia

University of Pennsylvania - Accounting Department

Date Written: October 2005

Abstract

Underpricing in IPOs is a significant cost of raising capital that theories purport arises from adverse selection at the IPO date. Disclosure is a tool firms can use to ameliorate adverse selection. We show that greater disclosure frequency in the pre-IPO period is associated with lower underpricing. The negative relation is significant only for informative disclosures, not for disclosures such as public relations announcements. The negative relation is significant after controlling for factors that affect ex ante uncertainty about the offering and for alternative mechanisms that firms can use to signal firm quality. The results are opposite for internet firms. They demonstrate a significant positive association between disclosure frequency and underpricing, consistent with claims that internet firms use underpricing to generate attention. Disclosure frequency also is associated with greater market liquidity subsequent to the IPO as measured by more traditional proxies: bid-ask spread and market depth.

Keywords: Disclosure, initial public offerings, cost of capital

JEL Classification: D82, G34, M41, M45

Suggested Citation

Schrand, Catherine M. and Verrecchia, Robert E., Information Disclosure and Adverse Selection Explanations for IPO Underpricing (October 2005). Available at SSRN: https://ssrn.com/abstract=316824 or http://dx.doi.org/10.2139/ssrn.316824

Catherine M. Schrand (Contact Author)

University of Pennsylvania - Accounting Department ( email )

3641 Locust Walk
Philadelphia, PA 19104-6365
United States
215-898-6798 (Phone)
215-573-2054 (Fax)

Robert E. Verrecchia

University of Pennsylvania - Accounting Department ( email )

3641 Locust Walk
Philadelphia, PA 19104-6365
United States
215-898-6976 (Phone)
215-573-2054 (Fax)

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
3,420
Abstract Views
14,746
Rank
6,439
PlumX Metrics